Insider · CIK 0001341597

MCCULLOGH ROBERT F JR

Reports to the SEC for 1 company · CHICAGO, IL

sec.gov

Transactions

Companies

Filings

CIK

0001341597

Forms 4 and 5

Insider transactions

34 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2013-05-20	Medite Cancer Diagnostics, Inc.A Award	Director, CEO and CFO, 10% Owner	AAward	+163M sh	$0.02	+$3.25M	167,524,501
2012-06-26	Medite Cancer Diagnostics, Inc.P Purchase	Director, CEO and CFO, 10% Owner	PPurchase	+1.3M sh	$0.02	+$26K	5,024,501
2012-02-14	Medite Cancer Diagnostics, Inc.P Purchase	Director, CEO and CFO, 10% Owner	PPurchase	+2.19M sh	$0.01	+$32.8K	3,723,148
2009-04-29	Medite Cancer Diagnostics, Inc.P Purchase	Director, CEO and CFO, 10% Owner	PPurchase	+400K sh	$0.25	+$100K	966,417
2009-04-29	Medite Cancer Diagnostics, Inc.M Exercise/Conversion	Director, CEO and CFO, 10% Owner	MExercise/Conversion	+25K sh	$0.25	+$6,250	991,417
2009-04-29	Medite Cancer Diagnostics, Inc.X Exercise of In-Money	Director, CEO and CFO, 10% Owner	XExercise of In-Money	+37.5K sh	$0.25	+$9,375	1,028,917
2009-04-29	Medite Cancer Diagnostics, Inc.X Exercise of In-Money	Director, CEO and CFO, 10% Owner	XExercise of In-Money	+12.5K sh	$0.25	+$3,125	1,041,417
2009-04-29	Medite Cancer Diagnostics, Inc.M Exercise/Conversion	Director, CEO and CFO, 10% Owner	MExercise/Conversion	+10K sh	$0.25	+$2,500	1,051,417
2009-04-29	Medite Cancer Diagnostics, Inc.Common stock warrantM Exercise/Conversion	Director, CEO and CFO, 10% Owner	MExercise/Conversion	−400K sh	—	—	0
2009-04-29	Medite Cancer Diagnostics, Inc.Common stock warrantM Exercise/Conversion	Director, CEO and CFO, 10% Owner	MExercise/Conversion	−25K sh	—	—	0
2009-04-29	Medite Cancer Diagnostics, Inc.Common stock warrantX Exercise of In-Money	Director, CEO and CFO, 10% Owner	XExercise of In-Money	−37.5K sh	—	—	0
2009-04-29	Medite Cancer Diagnostics, Inc.Common stock warrantX Exercise of In-Money	Director, CEO and CFO, 10% Owner	XExercise of In-Money	−12.5K sh	—	—	0
2009-04-29	Medite Cancer Diagnostics, Inc.Common stock warrantM Exercise/Conversion	Director, CEO and CFO, 10% Owner	MExercise/Conversion	−10K sh	—	—	0
2009-04-24	Medite Cancer Diagnostics, Inc.P Purchase	Director, CEO and CFO, 10% Owner	PPurchase	+5,000 sh	$0.34	+$1,700	566,417
2009-04-23	Medite Cancer Diagnostics, Inc.P Purchase	Director, CEO and CFO, 10% Owner	PPurchase	+5,000 sh	$0.35	+$1,750	1,242,950
2009-04-17	Medite Cancer Diagnostics, Inc.P Purchase	Director, CEO and CFO, 10% Owner	PPurchase	+4,000 sh	$0.41	+$1,640	561,417
2009-04-13	Medite Cancer Diagnostics, Inc.P Purchase	Director, CEO and CFO, 10% Owner	PPurchase	+3,000 sh	$0.42	+$1,260	1,237,950
2009-04-10	Medite Cancer Diagnostics, Inc.P Purchase	Director, CEO and CFO, 10% Owner	PPurchase	+5,000 sh	$0.45	+$2,250	557,417
2009-04-09	Medite Cancer Diagnostics, Inc.P Purchase	Director, CEO and CFO, 10% Owner	PPurchase	+5,000 sh	$0.45	+$2,250	552,417
2009-04-09	Medite Cancer Diagnostics, Inc.P Purchase	Director, CEO and CFO, 10% Owner	PPurchase	+60.8K sh	$0.43	+$26.1K	1,234,950
2009-04-08	Medite Cancer Diagnostics, Inc.P Purchase	Director, CEO and CFO, 10% Owner	PPurchase	+10K sh	$0.44	+$4,400	1,174,150
2009-04-06	Medite Cancer Diagnostics, Inc.P Purchase	Director, CEO and CFO, 10% Owner	PPurchase	+18K sh	$0.44	+$7,920	1,164,150
2009-04-03	Medite Cancer Diagnostics, Inc.P Purchase	Director, CEO and CFO, 10% Owner	PPurchase	+5,000 sh	$0.45	+$2,250	1,146,150
2009-04-02	Medite Cancer Diagnostics, Inc.P Purchase	Director, CEO and CFO, 10% Owner	PPurchase	+1,000 sh	$0.45	+$450	1,141,150
2009-04-02	Medite Cancer Diagnostics, Inc.P Purchase	Director, CEO and CFO, 10% Owner	PPurchase	+3,000 sh	$0.47	+$1,410	547,417
2009-04-01	Medite Cancer Diagnostics, Inc.P Purchase	Director, CEO and CFO, 10% Owner	PPurchase	+22K sh	$0.44	+$9,680	1,140,150
2009-03-25	Medite Cancer Diagnostics, Inc.P Purchase	Director, CEO and CFO, 10% Owner	PPurchase	+25K sh	$0.48	+$12K	1,118,150
2009-03-20	Medite Cancer Diagnostics, Inc.P Purchase	Director, CEO and CFO, 10% Owner	PPurchase	+40K sh	$0.56	+$22.4K	1,093,150
2009-03-19	Medite Cancer Diagnostics, Inc.P Purchase	Director, CEO and CFO, 10% Owner	PPurchase	+7,500 sh	$0.55	+$4,125	1,053,150
2009-03-18	Medite Cancer Diagnostics, Inc.P Purchase	Director, CEO and CFO, 10% Owner	PPurchase	+30K sh	$0.51	+$15.3K	1,045,650
2009-03-16	Medite Cancer Diagnostics, Inc.P Purchase	Director, CEO and CFO, 10% Owner	PPurchase	+11K sh	$0.52	+$5,720	1,015,650
2009-03-13	Medite Cancer Diagnostics, Inc.P Purchase	Director, CEO and CFO, 10% Owner	PPurchase	+10K sh	$0.55	+$5,500	1,004,650
2009-03-11	Medite Cancer Diagnostics, Inc.A Award	Director, CEO and CFO, 10% Owner	AAward	+59.5K sh	—	—	1,110,876
2007-12-28	Medite Cancer Diagnostics, Inc.P Purchase	Director, CEO and CFO, 10% Owner	PPurchase	+7,500 sh	$2.30	+$17.3K	410,750

Recent filings

Accepted (ET)
May 224
MCCULLOGH ROBERT F JR0001144204-13-031086
SEC(opens sec.gov)
Jun 284
MCCULLOGH ROBERT F JR0001144204-12-036869
SEC(opens sec.gov)
Feb 164
MCCULLOGH ROBERT F JR0001144204-12-009540
SEC(opens sec.gov)
May 54
MCCULLOGH ROBERT F JR0001209191-09-024508
SEC(opens sec.gov)
May 54
MCCULLOGH ROBERT F JR0001209191-09-024510
SEC(opens sec.gov)

Companies

Medite Cancer Diagnostics, Inc.Director, CEO and CFO, 10% Owner

Address

C/O CYTOCORE, INC. 414 N. ORLEANS ST. SUITE 510

CHICAGO, IL, 60654